PL EN


Preferences help
enabled [disable] Abstract
Number of results
2014 | 27 | 2 | 92-96
Article title

The effect of hormone replacement therapy on the expression of the alkaline phosphatase gene (ALPL) within the mucosal epithelium of the cheek and in peripheral blood lymphocytes

Content
Title variants
Languages of publication
EN
Abstracts
EN
In adult life, proper bone metabolism requires efficient regulation of bone formation and resorption processes. Bone turnover markers allow for assessing the rate of bone formation and resorption processes. In menopausal period, female patients experience gradual reduction in blood estradiol levels. The deficit of estrogens leads to enhanced osteoclastogenesis and bone resorption. Alkaline phosphatase (ALP) is a membranebound enzyme that stimulates the osteoblast activity and bone mineralization. It is synthesized by osteoblasts and incorporated into the newly formed bone tissue. The produced enzyme stimulates the osteoblast activity and bone mineralization. The goal of this study is to determine the effect of hormone replacement therapy in postmenopausal women on the expression of alkaline phosphatase gene (ALPL) within the mucosal epithelium of the cheek and in peripheral blood lymphocytes. The studies show that hormone replacement therapy has no significant effect on the increase in ALPL expression within the mucosal epithelium of the cheek. Only in women having undergone ovarectomy (OV), the epithelial ALPL expression level was higher than in the remaining groups.
Publisher

Year
Volume
27
Issue
2
Pages
92-96
Physical description
Dates
published
1 - 6 - 2014
received
1 - 7 - 2014
accepted
11 - 8 - 2014
online
25 - 11 - 2014
Contributors
  • Chair and Department of Oral Surgery, Medical University of Lublin, Karmelicka 7, 20-081 Lublin, Poland
author
  • Chair and Department of Oral Surgery, Medical University of Lublin, Karmelicka 7, 20-081 Lublin, Poland, lobosos@o2.pl
  • Chair and Department of Oral Surgery, Medical University of Lublin, Karmelicka 7, 20-081 Lublin, Poland
  • Department of Oral Surgery, Pomeranian Medical University, al. Powstańców Wlkp. 72, 70-111 Szczecin, Poland
  • Chair and Department of Oral Surgery, Medical University of Lublin, Karmelicka 7, 20-081 Lublin, Poland
References
  • 1. Chomczynski P., Sacchi N.: Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-9, 1987.
  • 2. Edman C.D.: Przekwitanie (klimakterium) (1989). In: Menopauza. Red. Buchsbauni HJ. PZWL. Warsaw, p. 34-44.
  • 3. Gajewska J., Ambroszkiewicz J., Laskowska-Klita T.: Wybrane markery obrotu kostnego w surowicy krwi dzieci w zależności od wieku i płci; Wiad, Lek., 2005, 58, 9-10, 2005.
  • 4. Garnero P., Hauser E., Chapuy M.C. et al.: Markers of bone predict hip fractures in elderly women. J Bone Min Res 11, 1531-38, 1996.
  • 5. Garnero P., Sornay-Rendu E., Claustrat B., Delmas P.D.: Biochemicalmarkers of bone turnover, endogenous hormones and the risk offractures in postmenopausal women. J. Bone Miner. Res., 15, 1526-36, 2000.[Crossref]
  • 6. Garnero P.: Bone markers in osteoporosis. Curr. Osteoporos. Rep., 7, 84-90, 2009.[Crossref]
  • 7. Hansen M., Overgaard K., Riis B., Christiansen C.: Role of peak bonemass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ, 303, 961-64, 1991.
  • 8. Jurkowski P., Mierzwińska-Nastalska E., Kostrzewa-Janicka J.: Use of Biochemical Markers of Bone Turnover in General Medicine and Dentistry. Dent. Med. Probl., 47, 2, 199-205, 2010
  • 9. Karczmarewicz E.: Markery obrotu kostnego. Nieinwazyjna ocena parametrow jakości kości. Osteoforum 2008
  • 10. Karczmarewicz E.: Wartość diagnostyczna markerow obrotu kostnego. Osteoforum 2006.
  • 11. Kr a en z l in M.E . : Bio chemi c a l Ma rk e r s of Bone Turnover and Osteoporosis Management. BoneKEy, 4, 191-203, 2007.
  • 12. Lerner U.H.: Bone remodeling in post-menopausal osteoporosis. J. Dent. Res., 85, 584-595, 2006.[Crossref]
  • 13. Marcinowska-Suchowierska (1999): Osteoporoza - diagnostyka, profilaktyka i leczenie. PZWL. Warszawa.
  • 14. Nawawi H.M. et al.: Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis. Malays J Pathol., 23, 79-88, 2001.
  • 15. Naylor K.E., Eastell R.: Measurement of biochemical markers of bone formation. In:Seibel M, Robins S, Bilezikian J, eds. Dynamics of bone and cartilage metabolism. Academic Press, 529-40, 2006.
  • 16. Rachoń D., Myśliwska J., Suchocka-Rachoń K.: Wpływ przezskornej estrogenoterapii na produkcję interleukiny-6 u kobiet w wieku pomenopauzalnym. Przegl. Menopauz., 2, 22-27, 2002.
  • 17. Rahnama M. et al.: Wpływ stosowania hormonoterapii zastępczej na stężenie fosfatazy zasadowej i fosfatazy kwaśnej w surowicy i ślinie u kobiet z niedoborem estrogenow. Przegl. Menopauz., 6, 506-9, 2012.
  • 18. Schiele F. et al.: Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem., 29, 634-41, 1983.
  • 19. Takahashi M. et al.: Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis. Clin. Endocrinol. (Oxf), 47, 177-83, 1997.[Crossref]
  • 20. Warenik-Szymankiewicz A., Stopień R.: Zastosowanie niskich dawek estrogenow jako nowej strategii w osteoporozie pomenopauzalnej. Terapia, 9, 11, 19-22, 2001.
  • 21. Warenik-Szymankiewicz A.: Hormonalna terapia zastępcza w okresie okołomenopauzalnym. Terapia, 5, 3-14, 1997.
  • 22. Weitzmann M., Pacifici R.: Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest., 116, 1186-94, 2006.[Crossref]
  • 23. Zgliczyński S.: Globalizacja w osteoporozie. JAMA PL, 5(1-2), 75-6, 2003.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_cipms-2014-0021
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.